Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-14

Clinical Trial Update: Comparison of Vortioxetine and Desvenlafaxine in Adult Patients Suffering From Depression [Phase 4]

View source ↗

Summary

Phase 4 trial comparing vortioxetine and desvenlafaxine in adults with Major Depressive Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desvenlafaxine (Desvenlafaxine)
  • Vortioxetine (vortioxetine)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED